CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 409 filers reported holding CRISPR THERAPEUTICS AG in Q3 2023. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,946 | +3954.1% | 836 | -95.0% | 0.02% | -95.9% |
| Q2 2023 | $936 | +19.8% | 16,668 | -3.5% | 0.42% | +10.9% |
| Q1 2023 | $781 | +10.2% | 17,268 | -1.0% | 0.38% | +2.5% |
| Q4 2022 | $709 | -99.9% | 17,448 | -7.5% | 0.37% | -42.6% |
| Q3 2022 | $1,232,000 | +5.9% | 18,853 | -1.5% | 0.64% | +11.5% |
| Q2 2022 | $1,163,000 | -3.3% | 19,140 | -0.1% | 0.57% | +17.9% |
| Q1 2022 | $1,203,000 | -16.7% | 19,160 | +0.5% | 0.48% | -10.0% |
| Q4 2021 | $1,444,000 | -27.4% | 19,060 | +7.3% | 0.54% | -35.8% |
| Q3 2021 | $1,989,000 | -2.9% | 17,766 | +1.3% | 0.84% | -0.2% |
| Q2 2021 | $2,049,000 | +1.9% | 17,541 | +6.3% | 0.84% | -13.7% |
| Q1 2021 | $2,010,000 | -17.8% | 16,498 | +3.4% | 0.97% | -22.2% |
| Q4 2020 | $2,444,000 | +24.4% | 15,962 | -1.2% | 1.25% | +20.5% |
| Q3 2020 | $1,964,000 | +61.2% | 16,157 | -2.5% | 1.04% | +37.6% |
| Q2 2020 | $1,218,000 | +47.6% | 16,567 | -1.2% | 0.76% | +35.5% |
| Q1 2020 | $825,000 | +27400.0% | 16,772 | +33444.0% | 0.56% | +27750.0% |
| Q4 2019 | $3,000 | +50.0% | 50 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $2,000 | 0.0% | 50 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $2,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |